// App-Quantinova.ai

: Randomised phase II trial of adaptive image guided radiotherapy in muscle invasive bladder cancer: Late toxicity and cancer outcomes.

Researchers

Presenter

  • Robert A Huddart

Principal Investigators

  • Abdullahi Omar

  • Alison Jane Birtle

  • Ka Ching Cheung

  • Ananya Choudhury

  • Farshad Foroudi

  • Hannah Gribble

  • Clare Griffin

  • Ann Henry

  • Ben Hindson

  • Rebecca Lewis

  • Duncan McLaren

  • Helen McNair

  • Ashok Nikapota

  • Omi Parikh

  • Isabel Syndikus

  • Mohini Anna Varughese

  • Amanda Webster

  • Emma Hall

Medical Centers

  • The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom

  • The Institute of Cancer Research, Division of Radiotherapy and Imaging and The Royal Marsden NHS Foundation Trust, Radiotherapy Department, London, United Kingdom

  • Royal Devon & Exeter NHS Foundation Trust, Blood Sciences, Exeter, United Kingdom

  • National Radiotherapy Trials Quality Assurance Group and University College Hospital, London, United Kingdom

  • Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United Kingdom

  • Sussex Cancer Centre, Brighton, United Kingdom

  • NHS Lothian, Department of Oncology, Edinburgh, United Kingdom

  • Canterbury District Health Board, Department of Haematology, Christchurch, New Zealand

  • Austin Health, Radiation Oncology, Austin, Australia

  • Leeds Teaching Hospitals NHS Trust, Division of Cancer Studies and Pathology, Leeds, United Kingdom

  • Clatterbridge Cancer Centre, Department of Radiotherapy, Liverpool, United Kingdom

Locations

  • New Zealand

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Adaptive

  • Double Blind/Blinded

  • Multiple Arm

  • Non-Comparative

  • Multinational

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved